Flerie Expands Access to Private Life Science Investments for Swedish Investors
Flerie offers Swedish investors unique access to private life science firms through an evergreen investment model, balancing risk and innovation in biotech.
Biotechnology business
All biotechnology business news
Flerie Expands Investor Access to Private Life Science Firms with Strategic Evergreen Model
Flerie, led by Ted Fjällman, offers investors unique access to private life science firms through an evergreen model emphasizing risk management and long-term value creation.
Swedish Innovations Showcase Advanced Technology Transforming Modern Industrial and Cell Therapy Sectors
Swedish leaders highlight integration of advanced technology in modern industrial work and cell therapy automation, showcasing innovation and market growth potential.
Oncopeptides Shows Promising Growth as It Pursues Profitability by 2026
Oncopeptides reports strong growth and aims for profitability by 2026 amidst expanding market reach.
Bico's Biosero Secures Major Contract Worth 143.6 Million SEK
Bico's subsidiary Biosero has secured a 143.6 million SEK contract with a global pharmaceutical firm.
Bioarctic Secures FDA Approval for Leqembi, Boosting Financial Outlook
Bioarctic has received FDA approval for Leqembi, indicating a major boost for its market position and financial health.